{"product_id":"global-tuberculosis-screening-market-growth-status-and-outlook-2023-2029","title":"Global Tuberculosis Screening Market Growth (Status and Outlook) 2023-2029","description":"\u003cp\u003eGlobal Tuberculosis Screening Market Growth (Status and Outlook) 2023-2029\u003c\/p\u003e\n\n\u003cp\u003eThe global Tuberculosis Screening market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.\u003c\/p\u003e\n\n\u003cp\u003eUnited States market for Tuberculosis Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.\u003c\/p\u003e\n\n\u003cp\u003eChina market for Tuberculosis Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.\u003c\/p\u003e\n\n\u003cp\u003eEurope market for Tuberculosis Screening is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.\u003c\/p\u003e\n\n\u003cp\u003eGlobal key Tuberculosis Screening players cover Qiagen, Sanofi, Oxford Immunotec, BioMerieux, Par Sterile, Bio-Rad Laboratories, Akonni Biosystems, Becton Dickinson and Abbott, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.\u003c\/p\u003e\n\n\u003cp\u003eLPI (LP Information)' newest research report, the “Tuberculosis Screening Industry Forecast” looks at past sales and reviews total world Tuberculosis Screening sales in 2022, providing a comprehensive analysis by region and market sector of projected Tuberculosis Screening sales for 2023 through 2029. With Tuberculosis Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tuberculosis Screening industry.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report provides a comprehensive analysis of the global Tuberculosis Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M\u0026amp;A activity. This report also analyzes the strategies of leading global companies with a focus on Tuberculosis Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tuberculosis Screening market.\u003c\/p\u003e\n\n\u003cp\u003eThis Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tuberculosis Screening and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tuberculosis Screening.\u003c\/p\u003e\n\n\u003cp\u003eThis report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis Screening market by product type, application, key players and key regions and countries.\u003c\/p\u003e\n\n\u003cp\u003eMarket Segmentation:\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by type\u003cbr\u003e\nActive Tuberculosis\u003cbr\u003e\nLatent Tuberculosis\u003c\/p\u003e\n\n\u003cp\u003eSegmentation by application\u003cbr\u003e\nHospital\u003cbr\u003e\nClinic\u003cbr\u003e\nDiagnostic Center\u003cbr\u003e\nLaboratories\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eThis report also splits the market by region:\u003cbr\u003e\nAmericas\u003cbr\u003e\n United States\u003cbr\u003e\n Canada\u003cbr\u003e\n Mexico\u003cbr\u003e\n Brazil\u003cbr\u003e\nAPAC\u003cbr\u003e\n China\u003cbr\u003e\n Japan\u003cbr\u003e\n Korea\u003cbr\u003e\n Southeast Asia\u003cbr\u003e\n India\u003cbr\u003e\n Australia\u003cbr\u003e\nEurope\u003cbr\u003e\n Germany\u003cbr\u003e\n France\u003cbr\u003e\n UK\u003cbr\u003e\n Italy\u003cbr\u003e\n Russia\u003cbr\u003e\nMiddle East \u0026amp; Africa\u003cbr\u003e\n Egypt\u003cbr\u003e\n South Africa\u003cbr\u003e\n Israel\u003cbr\u003e\n Turkey\u003cbr\u003e\n GCC Countries\u003c\/p\u003e\n\n\u003cp\u003eThe below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.\u003cbr\u003e\nQiagen\u003cbr\u003e\nSanofi\u003cbr\u003e\nOxford Immunotec\u003cbr\u003e\nBioMerieux\u003cbr\u003e\nPar Sterile\u003cbr\u003e\nBio-Rad Laboratories\u003cbr\u003e\nAkonni Biosystems\u003cbr\u003e\nBecton Dickinson\u003cbr\u003e\nAbbott\u003cbr\u003e\nHologic\u003cbr\u003e\nRoche\u003cbr\u003e\nThermo Fischer Scientific\u003cbr\u003e\nHain Lifescience\u003cbr\u003e\nEpistem\u003cbr\u003e\nCreative Diagnostics\u003cbr\u003e\nCepheid\u003cbr\u003e\nSiemens Healthineer\u003c\/p\u003e\n\n\u003cp\u003ePlease note: the online download version of this report is for a global site license.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"May, 2023 \/ 113 Pages \/ MCW16236565","offer_id":47652198449458,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-tuberculosis-screening-market-growth-status-and-outlook-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}